Australia's largest stock trading and investment forum Australia's #1 stock forum

CGB

0.00%

2.1¢ cann global limited

Gday matt,i am very new to investing and learning the share...

First 13 Last

Share
Profile

Follow
Jokerjanet

226 Posts.

18

03/05/17

22:32

Post #: 24454182
Share

Originally posted by Matt Adl ↑

Just went over where they are at and financials, there are few key points of contention that could determine a good entry point.

1st at 0.006 a share the orders are stacked @26m making it unlikely you will get in unless you buy at 0.007.

2nd DMX-200 with a 50% probability of clinical success - these figures need to improve somewhat through the testing phase as customers and doctors are going to prefer a higher % of success.

3rd product can license to a pharma partner in FY19 (base case) or FY18 (optimistic case) for US$30-50m upfront, US$100-200m in milestones and an 8-12% royalty. Finding a pharma partner and developing an upfront revenue followed by MS+R agreement is not guaranteed on these figures, if this translates succesfully your looking at estimated 13-30c company minimal; however, this is at least 1-2 years off.

4th product launch in FSGS in FY22 (base case) or FY21 (optimistic case) in the US and FY23 (base case) or FY22 (optimistic case) in Europe - long way till product launch, creating little interest in the stock or chance at recouping investment, it would be a MT/Long play for sure

5th company raises another $10m at $0.01 per share in order to complete both halves of the current Phase 2 for DMX-200 as well as move other pipeline elements forward - this seems like the best time for a short play, if you can acquire at 0.007 and they plan to CR at 0.01 translates to .3 raise; however, looking at current turnover, not sure how the SP will hit that target unless the subscription is to SI only.

Bio-pharma is highly speculative with significantly high peaks with substantial down-turns between, this company is still a fair way off and I would predict closer to the end of the year may be a better accumulation point if you don't want capital tied up. Right now it would be a pure punt, but if your keen on it give it a go and see how it turns out, will keep my eye on it and see how the company progresses.

Expand

Gday matt,i am very new to investing and learning the share market,i have been following a few of ur posts recently and firstly good work on ur gains this year...mate since everyone is picking ur brain just wondering on ur opinion on qbl vs eve?i hold qbl but was thinking of exiting (current price would be a 20% loss) and buying into eve at .7 or .8 ..again mate not asking for any advice im just looking for ur experianced opinion on where they could both be in the near term 3-6 months?

QBL Price at posting: 1.9¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PMT

High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%

RXM

Rex Minerals soars 60% on $390M Indonesian buyout deal from MACH Australia

HCH

Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant

WCN

White Cliff gears up to explore expanded Nunavut Cu-Ag-Au project in Canada

CXO

Core Lithium narrowly beats guidance on FY24 spodumene production but 1Y returns still shattered